comprehensive
WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.
Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.
advertisement
Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Previous article：
Analysis of telehealth claims data suggest service duplication
Next article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medical leaders decry Supreme Court decision on affirmative action
